Currently, new and easier ways of analyzing pharmaceutical drug forms and drug delivery mechanisms are being sought. Magnetic resonance imaging (MRI) is a non-invasive imaging technique that images drug forms such as tablets, liquids and topicals and drug form behavior in living organisms on both the tissue and cellular scale. The advantages of MRI include noninvasiveness, variable sample capacity and ease of transfer of phantom results to in vitro and in vivo studies. This review concerns the usefulness of clinical MRI that cannot be understated as this technique provides non-invasive and non-destructive insight into the properties of drug delivery systems. The research discussed here concerns the use of magnetic resonance, spectroscopy and chromatography to investigate selected pharmaceuticals and covers work of selecting drugs and antibodies for modification by synthesis for evaluation by MRI. Modifications have been aimed at improving therapeutic efficacy, delivery, and MRI. Modification conditions such as (pH, concentration, temperature, and the influence of other components present in the solutions) will be discussed to understand drug delivery system improvements and the reliability and repeatability of the results obtained. We hope to explore and expand the scope of pharmaceutical imaging with MRI for application in clinical medicine. Keywords. drug delivery systems, drug forms, magnetic resonance imaging, pharmaceuticals 
Introduction
Currently one of the most accurate non-invasive imaging methods is magnetic resonance imaging (MRI). This method allows one to make sections in any plane of both living organisms and non-anatomical structures. The signals we receive in MR depend on the object being tested and its properties. We have the ability to obtain data with morphological, functional and metabolic information. To non-invasively monitor drugs inside the human body is a challenge. However, MRI has not been yet used in its full capacity in the field of pharmacy. The application of MRI in the sphere of pharmacy began in 1995 and is constantly developing. The main applications of MRI in vitro are monitoring of water and other solvents, controlled release of dosage forms, hydration and diffusion. The use of MRI in pharmacy can provide a platform to transfer knowledge from an in vitro study to an in vivo study in drug delivery and controlled release of dosage forms. This transfer of knowledge already takes place in research and there are several example studies on neurological drugs, anticancer drugs and vitamins. The first application of MRI in pharmacy to study pharmaceutical tablets was published by Nebgen et al. where the authors showed the distribution of porosity in tablets which is an important subject for the generation of solid drugs. 1 In another work published by Hyde et al., the first quantitative MRI investigation based on a study of water migration from phosphate buffered solution into monolithic implants made of poly(glycolic acid-co-DL-lactic acid) produced by an extrusion process was conducted. 2 MRI is interesting for the magnetic properties of the nuclei of individual atoms. Each nuclei has its magnetic moment, which along with the applied magnetic field align with the lines of the field. The resulting weak net magnetization precess when disturbed from equilibrium. The frequency of precession (ω) is equal to the applied magnetic field (B) multiplied by the magnetogyric ratio (γ). The magnetogyric ratio, γ, is a property that varies for different nuclei, being largest for the hydrogen nucleus γ=42,58 s
. Radiowaves of angular frequency (ω) show a resonant interaction with the nuclei. A pulse of radio waves at this frequency can therefore be used to disturb the nuclei from equilibrium and set them into precession. Unfortunately, the MR signal is intrinsically weak, but increases in strength with increasing γ and B. MRI is therefore generally only applied to samples containing 1 H nuclei in high concentrations. One MRI technique is magnetic resonance spectroscopy (MRS). MRS is a diagnostic tool used to characterize tissues in terms of their chemical composition. [3] [4] [5] MRS is used to determine the chemical properties of a given area, focusing on the metabolites of the cells. The method is based on the effect of the chemical shift of the atom (nuclei of different cells precess at different frequencies). [6] [7] Most commonly performed experiment is single-voxel spectroscopy (SVS), where the signal is received from the selected location. Measurements are made using PRESS (Pointed-Resolved Spectroscopy) or STEAM (Stimuled Echo Aquisition Mode) sequences. Based on the recorded signal from a given voxel, a Fourier transform is calculated and then spectra are generated on which individual peaks correspond to individual metabolites. 8 A chemical shift graph of signal frequency in parts-per-million (ppm) is generated from the signal amplitude. The area under the peak corresponds to the concentration of the metabolite. This provides the possibility of quantification of signal by using internal standards. Measurements are made using the PRESS (Pointed-Resolved Spectroscopy) or STEAM (Stimuled Echo Aquisition Mode) sequences. Based on the recorded signal from a given voxel, Fourier transform is calculated, and then spectra are generated on which individual peaks correspond to individual metabolites. In a technique called Magnetic Resonance Spectroscopic Imaging (MRSI), we can obtain color maps where the concentration level of a particular metabolite is encoded by color. Identification and quantification of the metabolite such as N-acetyl l-aspartic acid (2.02 ppm), creatine (3.02 ppm), choline (3.22 ppm) and lactate (1.33 ppm) in phantom were performed using SAGE post processing software. In order to evaluate the performance of an MR system, an MR phantom has been developed to accurately analyze errors of MR systems. [9] [10] [11] This makes it possible to visualize the distribution of metabolites throughout the brain. This is problematic, however, because the data received may include voxel bleeding, that is, voxel noise from the surrounding voxels.
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MRI in pharmacy
The pharmaceutical sector has MRI related examples where formulations have been studied by observing tablet hydration and its effect during dissolution. MRI has been used to study internal mechanisms underlying in vitro drug release behavior in dosage forms, to monitor events within pharmaceutical processes, and in vivo to investigate the behavior of drug delivery systems in the body. 15 Examples of pre-clinical and in vitro MRI in new drug design studies include forms such as nanoparticles. [16] [17] [18] [19] [20] and nanogels. 21 Drug delivery systems use MRI to map drug transport and physiological response. Drug development [22] [23] and drug release [24] [25] [26] [27] [28] have also been studied by MRI. As shown in the PubMed Data Base, the number of total publications regarding the applications of MRI in pharmacy is constantly increasing.
The authors provide innovative and creative examples of the use of MRI research in pharmacy. Also, the number of publications on contrast agents has increased due to intensive searches for improvement of diagnostic methods. With MRI, we are able to provide non-invasive ways to visualize events during controlled-release dosage. Using MRI, we also have a tool that is helpful in understanding the processes that occur in drug metabolism. This may have a significant impact on the development of a new generation of pharmaceuticals 29 . Porosity and compaction density are important parameters in the manufacture of tablets by compression. Nebgen et al. have shown how MRI can provide a noninvasive method for mapping the density distribution within a compacted tablet at a spatial resolution of (95 μm). However, factors such as paramagnetic materials, water-air, and solid-air interfaces can cause MRI artifacts. [30] [31] [32] MRI can identify tissue macromolecules such as nucleic acids, lipids, collagen and proteoglycans using parameters such as chemical shift, relaxation rates, and magnetic spin couplings. The enormous potential of MR to translation of the complex physical and mathematical concepts into biological material is recently an emerging area of empirical and theoretical interests. The MR techniques to determine proton relaxation times spin -lattice T 1 and spin -spin T 2 are numerous. These include a method fully relaxed Inversion recovery (IR) 33 , Fast Inversion Recovery (FIR) 34 , Modified Fast Inversion Recovery (MFIR) 35 , Progressive Saturation (PS) 36 , Saturation Recovery (SR) 37 , Variable Nutation (VN) 38 , Look Locker (LL) 39 , choice of flip angles, delay intervals, and amount of signal averaging. These methods in a greater or lesser extent take advantage to provide a T 1 and T 2 measurements.
40-41 T 1 and T 2 in MRI are functions of spin density and also instrumental parameters such as the pulse sequence timing and slice selective sensitivity profile. 42 In liquids at higher temperatures T 1 and T 2 are almost equal. However, in solids and at low temperatures, there little molecular motion, T 1 may be many seconds while T 2 is only microseconds. The most commonly used methods in MRI for generating T 1 maps are based on the basic pulse sequences used for T 1 measurements in Nuclear Magnetic Resonance (NMR) spectroscopy: PS and IR. These radio-frequency pulse sequences can be combined with several imaging techniques and are used frequently in MRI. 43 The relaxation process is characterized by two exponential time constants T 1 and T 2 . The transient time-domain signal is digitized and stored in a computer. In MRI, the resultant magnetization aligned with the static magnetic field, which is called longitudinal magnetization, is tipped into the transverse plane, where it can be detected as an electric signal. This so-called transverse magnetization decays exponentially with a time constant T 2 . The longitudinal magnetization relaxes back to its equilibrium orientation parallel to the static magnetic field exponentially with a time constant T 1 . The mechanisms by which contrast agents enhance relaxation involve the magnetic moments. Relaxation does not occur spontaneously, it must be stimulated. Longitudinal magnetization relaxes toward equilibrium as excited spins undergo transitions to lower energy states. 44 These transitions must be stimulated by a changing magnetic field. A magnetic field oscillating in strength at the Larmor frequency supplies a quantum of energy exactly equal to the energy difference between the two states, thereby stimulating relaxation. The magnetic moments associated with particles such as nuclei, electrons, and atoms supply changing magnetic fields to stimulate relaxation ( Figure 2 ). These magnetic field fluctuations are vital for relaxation. 45 The first published calculated T 1 image was generated in 1978 using sequence PS showed in Figure 3 . Briefly, after the first 90 degree pulse, the magnetization is perturbed within the selected slice into the transverse plane. The transverse magnetization processes during the time interval TE and relaxes exponentially with a time constant as the 180 degree pulse refocuses any dephasing due to field in homogeneities. Longitudinal relaxation occurs during the interval TR until the next sequence repetition. If the next 90 degree pulse is applied the longitudinal magnetization has been allowed to recover completely during the intermediate period. 46 Most MR studies indicated that the often used pulse sequence to measure T 1 relaxation time is the IR measurements. 40 The pulse diagram for IR is shown in Figure 4 . Briefly, 180 degree pulse inverts the magnetization vector MZ. After this the magnetization lies along the negative z axis and MZ = -MZ. The T 1 relaxation makes the magnetization increase during time interval from -M0 throughout zero until it is back to original value MZ = M0. If at some time following the 180 degree pulse, the 90 degree pulse is applied MZ is rotated around the X axis and will then lie somewhere along the Y axis. A T 1 of a 90 degree pulse reads the relaxed magnetization.
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T 1 maps can also be generated by using a variable-tip-angle pulse during the MRI experiment. In this method, a pulse of tip angle zero-0 is used to perturb the magnetization, which is then left to partially relax back to its thermal equilibrium value during the short TR. As the excitation pulse is generally other than 90 degree only a fraction of the thermal equilibrium magnetization is tipped into the transverse plane. This transverse magnetization is then a function of both the pulse tip angle 0 and the amount of longitudinal relaxation that has occurred during the time interval TR. 48 In this case, the application of a 180 refocusing pulse to form a spin echo cannot be used, because such a pulse also would invert the magnetization that has remained along the longitudinal axis. Instead, an echo is formed through the use of gradients. This radio-frequency pulse sequence can then be incorporated into any imaging regime Figure 5 . The transverse relaxation during TE is now described by the effective transverse relaxation time constant. 49 Figure 5 presents a pulse sequence where T 1 derives from the ratio of the STE of the SE and is formed from the first two pulses. Equation 1 shows the ratio of STE and SE where TM is the time between the second and third pulses.
STE/SE = exp(-TM/T 1 )
This assumes perfect 90º pulses. Also to eliminate diffusion effects, a plot of 1/T 1eff against TE2 yields a straight line whose intercept at TE = 0 is 1/T 1 -T 1eff is the measured T 1 at each TE. 50 A SE sequence in which the magnetization stored on the z axis during TM is sampled with a series of pulses with increasing flip angles designed to give equal SI in the absence of T 1 relaxation. T 1 is calculated from SI=S 0 exp(TM/T 1 ). Two pulses produce a SE, and a series of low-angle pulses then produce a series of STEs. The T 1 is derived from the SE and STE intensities, which would all be the same if there were no T 1 relaxation. SE is very sensitive to flip-angle errors and could be improve by the SNR by changing the flip angle of the second pulse to 180 degree. It was forms a composite echo with a SE and a STE 90 degree out of phase and calculated T 1 from the phase of the signal. Phantom STE data are similar to IR data, but human STE data were not compared to IR phantom data (Figure 6-7) . 51 MRI and MRS measurements show that engineered liposomes can detect the mildly acidic pH of the tumor microenvironment with 0.2 pH unit precision and they release their content into C6 glioma tumors selectively, in vivo. 52 MRSI of the pH sensitive probe (+/-)2-(imidazol-1-yl)succinic acid disodium salt and a pH map of a tumor in vivo was investigated. Citrate, choline-containing compounds, creatine and polyamines have also been described by MRSI. The protons of Citrate resonate around 2.6 ppm, but the precise chemical shift and the scalar coupling of these protons depend on pH and cation concentration in cellular membranes. 53 MRSI was used in neurooncology but also in multiple sclerosis, stroke and epilepsy. However, a major challenge in conventional MRSI is the longer acquisition time required for adequate signal to be collected. 54 Studies to characterize the reliability of MRSI thermometry, including contributions from inter-scan and interexamination variability have been performed. In addition, measurments of the variation between subjects and assessment of the extent of brain temperature variation. 55 MRSI also provids spatially localized maps of metabolite concentrations. 56 MRSI provides a unique modality to non-invasively study tissue metabolism in vivo; it acquires metabolic information reflecting tissue function and provides a sensitive assessment of chemical alterations.
57 Table 1 -3 presents the applications of MRI to study the forms of drugs and properties.
The study provided by Zeitler and co-worker showed as a calibration set such that the MRI signal from the pore space of the tablet could provide a measure of tablet density. Different sets of production tablets were analyzed using the MRI method and the density distribution within the dosage form was determined. 76 Since T 1 of pure water can be 3-5 s and the image acquisition time is proportional to TR, this can lead to poor temporal resolution. In addition, the shortest achievable TE is restricted by the finite time required to turn the gradients on and off, limited by the hardware, as well as the time to record the signal. The use of low-field MRI (typically 0.5 Tesla) for pharmaceutical research, and specifically for tablet dissolution, has been limited partly due to the availability of instrumentation and also the perceived lack of sensitivity. 77 Nickel-doped agarose/ sucrose gels can be used as reference materials for MRI diffusion measurements and show excellent short-term stability with respect to ADC. A phantom made of these materials can be invaluable in optimizing DW-MRI protocols, developing novel pulse sequences for DW-MRI, or comparing ADC values among field strengths, vendors, and imaging centers. 78 Magnetic Block Ionomer Clusters with hydrophilic ionic cores and nonionic coronas have been prepared that have ultrahigh transverse NMR relaxivities together with capacities for incorporating high concentrations of polar antibiotic payloads. Magnetite-polymer nanoparticles were assembled by adsorbing the polyacrylate block of an aminofunctional poly(ethylene oxide-b-acrylate) (H2N-PEO-b-PAA) copolymer onto magnetite nanoparticles. 79 Magnetic nanoparticles possess unique magnetic properties and the ability to function at the cellular and molecular level of biological interactions making them an attractive platform as contrast agents for MRI and as carriers for drug delivery. Recent advances in nanotechnology have capsule plug dissolution study of capsules formulated from HPMC and L-dopa using flow through cell in a horizontal magnet improved the ability to specifically tailor the features and properties of MNPs for these biomedical applications. 80 The objective of this study was to prepare and characterize magnetic nanoparticles embedded in polylactide-co-glycolide matrixes (PLGA-MNPs) as a dual drug delivery and imaging system capable of encapsulating both hydrophilic and hydrophobic drugs. Magnetic resonance imaging was carried out both in vitro and in vivo to assess the efficacy of PLGA-MNPs as contrast agents. PLGA-MNPs showed a better contrast effect than commercial contrast agents due to higher T 2 relaxivity with a blood circulation half-life~47 min in the rat model. 81 The inverse relationship between T 1 and nanoparticle concentration accounts for the nonlinear increase in contrast, resulting in a modest leveling of the contrast effect at high concentrations when TE is kept to a minimum (~7 nM). The close agreement between the model and the phantom data supports extrapolations to lower concentrations of nanoparticles. If a CNR >= 5 is defined as the minimum diagnostically meaningful contrast, the model shows that only picomolar concentrations of nanoparticles need be present within a typically-sized imaging voxel to produce diagnostic contrast enhancement for molecular imaging.
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Conclusion
The number of papers regarding the applications of MRI in pharmacy shows a huge progress in MRI hardware and software applied to biomedical research. 
